Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03430245 · ClinicalTrials.gov registry record · NA
VelaShape III & UltraShape Power for Thigh Circumference Reduction
A NA study, sponsored by Syneron Medical.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03430245 is a NA study that has completed, run by Syneron Medical. The registered enrollment target is 16 participants.
The verdict
NCT03430245, a NA study, has completed, sponsored by Syneron Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Prospective, one-arm, baseline-controlled pilot study for the evaluation of the VelaShape III combined with UltraShape Power treatment for non-invasive circumference reduction to the thighs.
Interventions
- DEVICE VelaShape III
- DEVICE UltraShape Power
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-02-19 |
| Est. Completion | 2019-07-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03430245
The ClinicalTrials.gov registry entry for NCT03430245 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syneron Medical, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which VelaShape III is the first listed.
NCT03430245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03430245 about?
NCT03430245 is a clinical study titled "VelaShape III & UltraShape Power for Thigh Circumference Reduction". Prospective, one-arm, baseline-controlled pilot study for the evaluation of the VelaShape III combined with UltraShape Power treatment for non-invasive circumference reduction to the thighs.
What is the current status of trial NCT03430245?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2018-02-19. Estimated completion is 2019-07-03.
What interventions are being tested in trial NCT03430245?
The interventions under investigation include: VelaShape III (DEVICE), UltraShape Power (DEVICE).
Who is sponsoring clinical trial NCT03430245?
This trial is sponsored by Syneron Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.